|
|
Volumn 315, Issue 5816, 2007, Pages 1211-1213
|
|
Recruiting the cell's own guardian for cancer therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE;
ANTINEOPLASTIC AGENT;
IMIDAZOLINE;
MIRA 1;
MUTANT PROTEIN;
PRIMA 1;
PROTEIN MDM2;
PROTEIN P53;
UNCLASSIFIED DRUG;
IMIDAZOLINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
CANCER;
CELL ORGANELLE;
GENE;
ADENOVIRUS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
CANCER CELL;
CANCER RESEARCH;
CANCER THERAPY;
CELL GROWTH;
DNA DAMAGE;
DRUG RESEARCH;
GENE MUTATION;
GENE THERAPY;
GROWTH INHIBITION;
HUMAN;
LIVER TUMOR;
LYMPHOMA CELL;
MOUSE;
NONHUMAN;
ONCOGENE;
ONCOLOGY;
PRIORITY JOURNAL;
SHORT SURVEY;
TUMOR GROWTH;
TUMOR SUPPRESSOR GENE;
ANIMAL;
ARTICLE;
CANCER TRANSPLANTATION;
CLINICAL TRIAL;
DRUG SCREENING;
GENETIC ENGINEERING;
GENETICS;
METABOLISM;
MUTATION;
NEOPLASM;
PATHOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CLINICAL TRIALS;
DRUG SCREENING ASSAYS, ANTITUMOR;
GENES, P53;
GENETIC ENGINEERING;
HUMANS;
IMIDAZOLINES;
MICE;
MUTATION;
NEOPLASM TRANSPLANTATION;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-MDM2;
PYRIMIDINES;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 33847619209
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.315.5816.1211 Document Type: Short Survey |
|
Times cited : (23)
|
|
References (0)
|